Business Context and Reporting Period
Company: Willis Towers Watson Public Limited Company (WTW)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: WTW is a global advisory, broking, and solutions company operating in two segments: Health, Wealth & Career (HWC) and Risk & Broking (R&B). The company serves approximately 49,000 colleagues across 140+ countries, providing data-driven solutions in people, risk, and capital management.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Revenue | $9.93 billion | $9.48 billion |
| Net Income (Loss) Attributable to WTW | ($98) million | $1.06 billion |
| Diluted EPS | ($0.96) | $9.95 |
| Adjusted Operating Income | $2.38 billion | $2.08 billion |
| Adjusted EBITDA | $2.71 billion | $2.43 billion |
| Free Cash Flow | $1.38 billion | $1.19 billion |
| Total Debt | $5.31 billion | $5.22 billion |
| Cash and Cash Equivalents | $1.89 billion | $1.42 billion |
Material Changes vs. Prior Period
- Net Loss vs. Profit: The company reported a net loss of $98 million in 2024 compared to a net income of $1.06 billion in 2023. This reversal was primarily driven by a $1.04 billion goodwill impairment charge and a $337 million loss on disposal associated with the sale of the TRANZACT business.
- Revenue Growth: Total revenue increased 5% to $9.93 billion. Organic revenue growth was also 5%, driven by strong performance in both HWC and R&B segments.
- Segment Performance:
- HWC: Revenue grew 3% to $5.78 billion; Operating income increased to $1.72 billion.
- R&B: Revenue grew 8% to $4.04 billion; Operating income increased to $958 million.
- Transformation Program: The three-year Transformation program concluded in Q4 2024, incurring cumulative costs of $1.115 billion and capital expenditures of $130 million. The program identified $473 million in cumulative annualized run-rate savings.
Guidance, Outlook, and Risks
- Outlook: Management expects to continue realizing benefits from the Transformation program. The company anticipates receiving a $750 million earnout payment related to the 2021 Willis Re divestiture in the first half of 2025.
- Capital Allocation: The company repurchased $901 million of shares in 2024. As of December 31, 2024, approximately $1.4 billion remains on the current share repurchase authority. A quarterly dividend of $0.92 per share was declared in February 2025.
- Key Risks:
- Strategic Execution: Risks related to integrating acquisitions, managing organizational changes, and realizing anticipated benefits from the Transformation program.
- Market Conditions: Exposure to macroeconomic trends, inflation, interest rate fluctuations, and geopolitical conflicts (e.g., Russia-Ukraine, Middle East).
- Cybersecurity: Ongoing threats of data breaches and cyberattacks, including those leveraging generative AI.
- Regulatory: Evolving regulations regarding data privacy (GDPR, CCPA), ESG reporting, and tax laws (e.g., Pillar Two minimum tax).
Investor Verification Checklist
- Impairment Details: Verify the specific assumptions and fair value calculations used for the $1.04 billion goodwill impairment on the Benefits, Delivery & Administration (BDA) reporting unit.
- TRANZACT Sale: Confirm the final purchase price adjustments and the status of the Transition Services Agreement (TSA) with the buyer.
- Willis Re Earnout: Monitor the realization of the $750 million earnout receivable expected in H1 2025 and the associated tax implications.
- Transformation Savings: Track the realization of the $473 million in annualized run-rate savings and the impact on future operating margins.
- Debt Covenants: Review compliance with financial covenants, specifically the consolidated EBITDA to cash interest expense ratio and funded indebtedness to EBITDA ratio.